U.S. Healthtech Stock News

NasdaqGS:SBLK
NasdaqGS:SBLKShipping

3 Shipping Stocks Retail Investors Are Watching After Strait Of Hormuz Risks

Geopolitical tension in the Gulf, disruptions around the Strait of Hormuz and higher energy prices are putting fresh attention on shipping and maritime logistics stocks. These companies sit close to the action when trade routes are disrupted and freight risk premiums move, which can reshape costs, revenues and investor sentiment. This article looks at three stocks from a Shipping and Maritime Logistics Companies screener that are directly exposed to the latest US Iran conflict news. Each...
NYSE:PK
NYSE:PKHotel and Resort REITs

Is Park Hotels & Resorts (PK) Undervalued Following Positive Analyst Sentiment?

Park Hotels & Resorts (PK) is back on investor radars after positive analyst sentiment highlighted its strong value ranking and suggestion of undervaluation compared with peers, prompting fresh interest in the stock. See our latest analysis for Park Hotels & Resorts. The recent interest in Park Hotels & Resorts has come alongside a strong 90 day share price return of 32.38% and a year to date share price return of 37.79%. The 1 year total shareholder return of 51.24% points to momentum that...
NasdaqGS:WDFC
NasdaqGS:WDFCHousehold Products

WD-40 (WDFC) Following Cost Pressures And Supply Disruptions Still Looks Undervalued

WD-40 (WDFC) is back in focus after its latest quarterly results, where higher input costs and supply disruptions linked to the Iran war have raised fresh questions for investors about future profitability. See our latest analysis for WD-40. WD-40’s share price fell 2.9% on the day of the earnings update and is down 4.7% over the past week, but a 21.8% year to date share price return and 13.4% 1-year total shareholder return suggest momentum has generally been positive over a longer...
NasdaqGS:BANR
NasdaqGS:BANRBanks

Is Banner (BANR) Turning Short-Term Revenue Beats Into Sustainable Momentum Or Just Timing Cycles?

Earlier this week, regional banking group Banner Corporation (NASDAQ:BANR) reported quarterly results following last quarter’s revenue beat and year-on-year growth, against a backdrop of market forecasts for slower revenue expansion this time. The tension between Banner’s recent revenue outperformance and expectations for cooling growth has turned its earnings updates into a closely studied indicator of its momentum. With investors focused on whether Banner’s revenue momentum is slowing...
NasdaqGS:SLDE
NasdaqGS:SLDEInsurance

3 Founder Run Stocks Investors Are Researching As Rates Stay High

Founder-led companies can offer something that is hard to measure, but important when inflation, energy costs and interest rates keep markets on edge: leaders with real skin in the game. When the person setting the strategy is also a major shareholder, incentives tend to be closely aligned with yours as an investor. This Founder-Led Companies screener focuses on businesses where the original builder is still in charge and personally committed to the long haul at a time when trade tensions,...
NasdaqGS:CNXN
NasdaqGS:CNXNElectronic

PC Connection (CNXN) Rallies To $79.78, Is The Valuation Still Justified?

PC Connection (CNXN) has drawn investor attention after recent share performance, with the stock closing at $79.78 and delivering double-digit returns over the past month and the past three months. See our latest analysis for PC Connection. For context, PC Connection’s recent move to $79.78 sits within a strong run, with a 30-day share price return of 13.05% and a year-to-date share price return of 40.26%, alongside a 5-year total shareholder return of 86.08%. Taken together, these figures...
NasdaqGS:HALO
NasdaqGS:HALOBiotechs

Halozyme Therapeutics (HALO) Lands Incyte Deal On A Valuation That Still Looks Undervalued

Halozyme Therapeutics (HALO) drew fresh attention after signing a global partnership and licence agreement with Incyte to apply its Enhanze technology to subcutaneous formulations of INCA033989 for mutCALR myeloproliferative neoplasms. See our latest analysis for Halozyme Therapeutics. Halozyme Therapeutics has also been in focus for its share price performance, with a 30 day share price return of 12.46% and a 1 year total shareholder return of 37.86% pointing to building momentum around the...
NYSE:ARW
NYSE:ARWElectronic

How Investors May Respond To Arrow Electronics (ARW) Being Flagged As A Top Value Stock

Recently, Zacks identified Arrow Electronics as a top-ranked value stock, citing its A-grade valuation profile and metrics that signal it may be priced below comparable industry peers. What stands out is that this value-focused recognition is closely tied to a supportive earnings outlook, suggesting fundamentals rather than short-term sentiment are driving renewed investor interest. Next, we’ll examine how this value-oriented reappraisal, underpinned by a favorable earnings outlook,...
NasdaqGS:DLTR
NasdaqGS:DLTRConsumer Retailing

Dollar Tree (DLTR) Beat First Quarter Estimates, Is The Stock Now Fully Valued?

Dollar Tree (DLTR) is back in focus after reporting first quarter earnings and revenue that came in ahead of expectations, along with plans to close about 75 stores and open roughly 400 in fiscal 2026. See our latest analysis for Dollar Tree. At a share price of $126.38, Dollar Tree has recently gained momentum, with a 30 day share price return of 13.19% and a 90 day share price return of 21.72%, while the 1 year total shareholder return of 12.53% sits alongside a weaker 3 year total...
NYSE:MAC
NYSE:MACRetail REITs

Macerich (MAC) Has Rallied Sharply, Is It Now Overvalued?

Macerich (MAC), a U.S. retail-focused REIT, has drawn renewed attention after recent trading showed solid short term and past 3 months gains, prompting investors to reassess the stock’s valuation and income profile. See our latest analysis for Macerich. Beyond the latest move, Macerich’s share price return has been strong over multiple timeframes. Over 30 days the share price return is 8.3%, over 90 days it is 18.4% and the year to date share price return is 38.2%. Long term investors have...
NYSE:NVO
NYSE:NVOPharmaceuticals

Novo Nordisk (NVO) Stock May Sit Below Fair Value Despite EU Wegovy Approval

Novo Nordisk stock has delivered a decline of 35.3% over the past three years, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and the earnings multiples currently point to an undervalued profile, creating a clear tension between price performance and valuation checks. Over the last three years, Novo Nordisk shares are down 35.3%, which may make the current level look more like a reset than a continuation of past gains. Regulatory momentum around Wegovy and an ongoing share...
NasdaqGS:DKNG
NasdaqGS:DKNGHospitality

Is DraftKings' (DKNG) Alberta Launch a Signal About Its North American Scale Ambitions?

DraftKings Inc. has already launched its online sportsbook and casino, along with the Golden Nugget Online Gaming brand, in Alberta, making the province its second Canadian market and the 34th jurisdiction in North America to offer DraftKings Sportsbook. This move meaningfully extends DraftKings’ North American footprint by adding a new regulated province where it can offer a broad suite of betting and casino products under both the DraftKings and Golden Nugget brands. We’ll now examine how...
NYSE:BAP
NYSE:BAPBanks

Credicorp (BAP) Could Be 1% Undervalued Following Dividend Driven Interest

Recent coverage of Credicorp (BAP) has centered on its profile as a dividend stock, supported by a favorable Zacks ranking and expectations around earnings and payout trends, which appear to be influencing recent trading interest. See our latest analysis for Credicorp. Credicorp’s share price has pulled back slightly in the last day and week. However, the 90 day share price return of 16.09% and year to date gain of 35.07% suggest momentum has been building, alongside a 1 year total...
NYSE:KSS
NYSE:KSSMultiline Retail

Is Kohl’s (KSS) Efficiency Push Quietly Rewriting Its Long-Term Retail Investment Narrative?

Kohl’s recently reported quarterly results showing revenue in line with analyst expectations but missing its full-year EPS guidance, while CEO Michael Bender emphasized progressive improvements in expense management, inventory cleanliness, and the balance sheet. Despite posting the slowest revenue growth among general merchandise retail peers, Kohl’s operational focus and cleaner inventories have become a central point of interest for investors assessing its longer-term trajectory. We’ll now...
NasdaqGS:OSIS
NasdaqGS:OSISElectronic

OSI Systems (OSIS) Stock Looks Cheap On Cash Flow Even After Strong Returns

OSI Systems stock has pulled back recently after a strong multi year run, yet the company still screens as undervalued on both its intrinsic value estimate, based on a Discounted Cash Flow (DCF) model, and market based multiples. That combination puts the focus squarely on whether the recent share price weakness has moved the stock further away from, or closer to, its estimated intrinsic value. Over the last 5 years, OSI Systems has delivered a total return of about 116.7%, which means long...
OTCPK:LKNC.Y
OTCPK:LKNC.YHospitality

Luckin Coffee (OTCPK:LKNC.Y) Could Be 30% Below Fair Value As It Enters New York

Luckin Coffee (OTCPK:LKNC.Y) is entering New York City, drawing fresh attention to how its speed-focused, cashless model and value positioning could affect competitive pressures on established U.S. coffee chains and their investors. See our latest analysis for Luckin Coffee. That New York move is landing at a time when Luckin Coffee’s short term momentum is mixed, with a 1 day share price return of 4.74% and a year to date share price return down 9.49%, while the 5 year total shareholder...
NYSE:FUL
NYSE:FULChemicals

H.B. Fuller (FUL) Could Be 24% Below Fair Value On Credit Refinancing

H.B. Fuller (FUL) has reworked its primary credit agreement by refinancing term and revolving loans, extending their maturity to 2031 and securing lower interest margins, while also expanding its revolving facility by $100 million. See our latest analysis for H.B. Fuller. Despite the refinancing and the recent dividend declaration, H.B. Fuller’s share price has been under pressure, with a 30 day share price return down 14.54% and a 1 year total shareholder return down 5.68%. This suggests...
NYSE:PARR
NYSE:PARROil and Gas

Do Rising 2026 Earnings Estimates Reframe Par Pacific Holdings’ (PARR) Value Story or Just Expectations?

In recent days, analysts have raised their 2026 earnings estimates for Par Pacific Holdings and highlighted its strong fundamentals and attractive value profile. This upgrade cycle underscores how shifts in earnings expectations and valuation metrics can reshape perceptions of Par Pacific’s long-term earnings power and risk profile. We’ll now examine how these upgraded earnings forecasts, particularly the focus on Par Pacific’s value credentials, may influence its existing investment...
NasdaqGS:GTX
NasdaqGS:GTXAuto Components

Garrett Motion (GTX) Keeps Beating Earnings, Is It Still 12% Undervalued?

Garrett Motion (GTX) is back in focus after repeatedly surpassing earnings expectations, with recent quarters showing double digit percentage surprises that have drawn fresh attention to the stock’s underlying operating performance. See our latest analysis for Garrett Motion. Despite a recent pullback, with a 1 month share price return down 8.68% from a last close of US$31.34, Garrett Motion still shows strong momentum, with a 90 day share price return of 57.65% and a 1 year total shareholder...
NasdaqGS:HUBG
NasdaqGS:HUBGLogistics

Hub Group (HUBG) Accounting Fallout Leaves A Valuation Question

Hub Group (HUBG) is under intense scrutiny after admitting its recent financial statements were unreliable. The company acknowledged ineffective internal controls and misstated costs, which have triggered class action litigation and leadership changes. See our latest analysis for Hub Group. Despite the controversy around Hub Group’s financial reporting, the stock’s recent price action has been resilient, with a 30 day share price return of 13.46% and a year to date share price return of...
NasdaqGS:HLNE
NasdaqGS:HLNECapital Markets

Intellia Stock And 2 Growth Shares With Clear Earnings Upside

With inflation concerns linked to higher energy prices, mixed signals on global growth, and bond yields reacting to every new policy hint, many investors are looking for companies where earnings expectations and balance sheet strength are clearly spelled out. That is exactly what the Healthy high growth potential screener focuses on. It highlights stocks where analysts forecast solid earnings growth over the next 3 years and financial positions that pass basic quality checks. This article...